| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ratings for FIGS (NYSE:FIGS) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 1 | 4 | 1 | 2 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 1 |
| 2M Ago | 0 | 0 | 0 | 1 | 0 |
| 3M Ago | 0 | 1 | 2 | 0 | 1 |
Analysts have set 12-month price targets for FIGS, revealing an average target of $6.04, a high estimate of $11.00, and a low estimate of $4.25. Highlighting a 16.11% decrease, the current average has fallen from the previous average price target of $7.20.
The analysis of recent analyst actions sheds light on the perception of FIGS by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Matt Koranda | Roth MKM | Lowers | Buy | $6.75 | $7.50 |
| Dana Telsey | Telsey Advisory Group | Maintains | Market Perform | $6.00 | $6.00 |
| Dana Telsey | Telsey Advisory Group | Maintains | Market Perform | $6.00 | $6.00 |
| Brooke Roach | Goldman Sachs | Lowers | Sell | $4.25 | $4.85 |
| Lorraine Hutchinson | B of A Securities | Lowers | Underperform | $4.50 | $8.50 |
| Adrienne Yih | Barclays | Lowers | Equal-Weight | $5.00 | $7.00 |
| Brooke Roach | Goldman Sachs | Lowers | Sell | $4.85 | $6.75 |
| Dana Telsey | Telsey Advisory Group | Lowers | Market Perform | $6.00 | $11.00 |
| Dana Telsey | Telsey Advisory Group | Maintains | Outperform | $11.00 | - |
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into FIGS's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on FIGS analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company markets and sells its products in the United States. Sales are generated through the Company's digital platforms.
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, FIGS showcased positive performance, achieving a revenue growth rate of 0.01% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: FIGS's net margin is impressive, surpassing industry averages. With a net margin of 6.9%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.73%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): FIGS's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.19%, the company showcases efficient use of assets and strong financial health.
Debt Management: FIGS's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: FIGS
